{"id":791577,"date":"2024-12-02T09:17:50","date_gmt":"2024-12-02T14:17:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/"},"modified":"2024-12-02T09:17:50","modified_gmt":"2024-12-02T14:17:50","slug":"humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/","title":{"rendered":"Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">DURHAM, N.C., Dec.  02, 2024  (GLOBE NEWSWIRE) &#8212; Humacyte, Inc.\u00a0(Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced that\u00a0Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, will participate in a fireside chat presentation at the\u00a0Piper Sandler 36th Annual Healthcare Conference, in\u00a0New York, NY\u00a0on\u00a0Thursday, December 5, 2024. Management will also be available for one-on-one meetings.<\/p>\n<p>\n        <strong>Event:<\/strong> Piper Sandler 36th Annual Healthcare Conference<br \/><strong>Location:<\/strong> The Lotte New York Palace, NY <br \/><strong>Presentation:<\/strong> Thursday, December 5, 8:00 a.m. EST <br \/><strong>Webcast:<\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IsnieBlEGOZbZBknXWeuGzRfuBB6rn-GNHPSCdW6OAkQGqvSpoOR8kE6GtVz6CO33F7KjVcY58KDJxcE0XeZtTEXxxBzEo1EN2hxwOKb20wM09VN3Gm2K1EfJwy3GkxXk5KdU1mz95WvNC6cVPgKilfx9YSqjDHwFk9uQDruUQeB9kjRVvsild_i3YQzZETEeeq4tTpv8t9WxWKi52ZnrkNAo4i0dPLwb85nVJcSWeFrnwptL292T0R_xnuWclExrK6rmYu4nd_jHhWA0MGxR4UVDJm9Gimq4Tn05t1ezuUsiScv41vN4lkyh9E2_upNL-g7Lqx9W6nYTAflPtLtToo09Otbix6y4NB_SP3syfHJjuLWHft9NqO1AQs8pd3ETGQj_ocxxgt1HsHjW9sPvbVptHRwsv6Bo60xUdE9M2o6Hj-YZU6ql0eXeCtcSmHT3G24ftXJRJzFE6EEtOsVeveO_edqlbJo9Rv1wnT_Mj2LEXvQx427qo8J6QnvRuPXeJSlNyTUJl9-IEzbzFHsPfYXYu0S6r1n345A1jxh-TOLExgi5BlNlYtdJIvD_y6Q9PNZ7FRgofSwtne7dXutDYz0YzfY80Q_rYg4RE90GUskCuGCsQydVALWWJigr9ONrp5YFks4eYTW9tJxKIq4M5vZlLsST2k4gRjvRNyJQx58-MVj_W1tfAKbhkriH0bBPxPu4o5TWH7y7BJAdJD_VQ==\" rel=\"nofollow\" target=\"_blank\">https:\/\/event.webcasts.com\/<\/a><\/p>\n<p>A replay will be available for a limited time following the presentation on the Events &amp; Presentations portion of the\u00a0Humacyte\u00a0website.<\/p>\n<p>\n        <strong>About\u00a0Humacyte<\/strong>\n      <\/p>\n<p>Humacyte, Inc.\u00a0(Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues, advanced tissue constructs, and organ systems designed to improve the lives of patients and transform the practice of medicine.\u00a0Humacyte\u00a0develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Humacyte\u2019s initial product candidates, a portfolio of ATEVs, are currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous (AV) access for hemodialysis, and peripheral artery disease. A Biologics License Application for the ATEV in the vascular trauma indication is currently under review by the FDA and was granted Priority Review. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte\u2019s 6mm ATEV for AV access in hemodialysis was the first product candidate to receive the FDA\u2019s Regenerative Medicine Advanced Therapy (RMAT) designation and has also received FDA Fast Track designation. Humacyte\u2019s 6mm ATEV for urgent arterial repair following extremity vascular trauma and for advanced PAD also have received an RMAT designations. The ATEV received priority designation for the treatment of vascular trauma by the\u00a0U.S.\u00a0Secretary of Defense. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9wxCaHSUQ0O_hEkJMGtysqGVAsChoj_oc56ISlima23wKGZrOEJtXHDqEPJZUNVpHcwdBpeEAsjtv_CPcwzUkQ==\" rel=\"nofollow\" target=\"_blank\">www.Humacyte.com<\/a>.<\/p>\n<p>\n        <strong>Humacyte Investor Contact:<\/strong><br \/>\n        <br \/>Joyce Allaire<br \/>LifeSci Advisors LLC<br \/>+1-617-435-6602<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wZCUuVjiGH-zxShzVF2C-I-0PcUo3btXsQdIPUnVuZTy3VlQxV2xH6Pbzlt3i3AtCp18gmvWgeLMJQ6XPsPNxL7ZvsYKDWzWSRYmdDqEHBJcnwFafyoWQ90BFtMd1uyhAT06kdwCo4e0e0S5WRwUlwgtw7csvA0dT5zqTI7u-IKIz3FcQkYDoTCUEGbgbMvY5a2N8l-FMed52ymtbM0zhheP5XweZ9icLpqFYDNwCn-q9HyQH8XCw2chSQtG7ujldzuFpWYUJ9ASWa1nFU-hVbx-mH-s_D5v_Zwsal93rgo=\" rel=\"nofollow\" target=\"_blank\">jallaire@lifesciadvisors.com<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q_MMfQHR_cJN5v3giUqr2JioEf6IWwZc1MqMY08As4LWiSN_f4XarfcPlXQXR3ueeioJ1o6rZW3GOySCdZd1D33mQgSql5vaafoXapusgV8p_NrN8_O7nqp32B2luNfGR8FAapAYUyCWKpWVvQoCjoKna-2wWTVmt1lqMCsyGYs8bD5nZ6py2YIGBHy4G3oiCdiZP3nevReBF572yWQW1YZHUzTOPimlzdNHfG-9O9MtS5ybsDZ9RExf4s254j8Mom32QLn843DLg5I-y8mKNA==\" rel=\"nofollow\" target=\"_blank\">investors@humacyte.com<\/a><\/p>\n<p>\n        <strong>Humacyte Media Contact:<\/strong><br \/>\n        <br \/>Rich Luchette<br \/>Precision Strategies<br \/>+1-202-845-3924<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8T8sMP4V22dCFkXco3uDRVLtZ0aPgO56f1rnmHbX8wagEWYk1ebh2OcaGz3OgwyNE-kgDBRkmoG7SU_caADrBKYy5NkcgP24xl74FyFt7x0QlrvYvW-EDO6kG3AUxRaD1kO_3u56Kp1zOswU4-mmnQ6tOXscV2RuHw-Y3crqfzbGozVrMyl-8ExjM1NHxD5W_FXDlVcqJ-PUOCkMl1ZgWDuERBCAWGuhG5dyMUZGS0gxOePjDWzP7_4MBhWU6arcDz7ODxjytuUZM90d9y_IMXNE6fV8SK1sudlaUIPD3dg=\" rel=\"nofollow\" target=\"_blank\">rich@precisionstrategies.com<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7Pf8F4uJS_ueLiRuO5a8kqTPINNHc0epbwNzEeFjgq4BYoeK6_c5ZMjN6EiBIE6DqhtKCIiGmlh-N1cPb_lD0BMn6fvx_df7Wg7Lz2tiXWKTA3X1JqHdnFLFEF351FLQqAreJiWIRmqdqE7YIBn8OOi2KodEKRgk65lDjmVqkvpBrwA5pdMxEs0DbCGt6fKHFjT92_vOYTyss2naGUAvrkb_lEA6okGYWGjiXYLWExgAZD9o3n75xlbYZV1wbvr5Pe8J5WnuLsVWlyau9thuWA==\" rel=\"nofollow\" target=\"_blank\">media@humacyte.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjQxMyM2NjE3OTYwIzIyMDk0MzY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NjFkNDFkNDMtYmVkOC00MWNjLTk0MTUtOTExMzM0MjRkZmM0LTEyMjA5ODk=\/tiny\/Humacyte-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>DURHAM, N.C., Dec. 02, 2024 (GLOBE NEWSWIRE) &#8212; Humacyte, Inc.\u00a0(Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced that\u00a0Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, will participate in a fireside chat presentation at the\u00a0Piper Sandler 36th Annual Healthcare Conference, in\u00a0New York, NY\u00a0on\u00a0Thursday, December 5, 2024. Management will also be available for one-on-one meetings. Event: Piper Sandler 36th Annual Healthcare ConferenceLocation: The Lotte New York Palace, NY Presentation: Thursday, December 5, 8:00 a.m. EST Webcast:https:\/\/event.webcasts.com\/ A replay will be available for a limited time following the presentation on the Events &amp; Presentations portion of the\u00a0Humacyte\u00a0website. About\u00a0Humacyte Humacyte, Inc.\u00a0(Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-791577","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DURHAM, N.C., Dec. 02, 2024 (GLOBE NEWSWIRE) &#8212; Humacyte, Inc.\u00a0(Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced that\u00a0Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, will participate in a fireside chat presentation at the\u00a0Piper Sandler 36th Annual Healthcare Conference, in\u00a0New York, NY\u00a0on\u00a0Thursday, December 5, 2024. Management will also be available for one-on-one meetings. Event: Piper Sandler 36th Annual Healthcare ConferenceLocation: The Lotte New York Palace, NY Presentation: Thursday, December 5, 8:00 a.m. EST Webcast:https:\/\/event.webcasts.com\/ A replay will be available for a limited time following the presentation on the Events &amp; Presentations portion of the\u00a0Humacyte\u00a0website. About\u00a0Humacyte Humacyte, Inc.\u00a0(Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable &hellip; Continue reading &quot;Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-02T14:17:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjQxMyM2NjE3OTYwIzIyMDk0MzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference\",\"datePublished\":\"2024-12-02T14:17:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\\\/\"},\"wordCount\":374,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxMjQxMyM2NjE3OTYwIzIyMDk0MzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\\\/\",\"name\":\"Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxMjQxMyM2NjE3OTYwIzIyMDk0MzY=\",\"datePublished\":\"2024-12-02T14:17:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxMjQxMyM2NjE3OTYwIzIyMDk0MzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxMjQxMyM2NjE3OTYwIzIyMDk0MzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference - Market Newsdesk","og_description":"DURHAM, N.C., Dec. 02, 2024 (GLOBE NEWSWIRE) &#8212; Humacyte, Inc.\u00a0(Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced that\u00a0Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, will participate in a fireside chat presentation at the\u00a0Piper Sandler 36th Annual Healthcare Conference, in\u00a0New York, NY\u00a0on\u00a0Thursday, December 5, 2024. Management will also be available for one-on-one meetings. Event: Piper Sandler 36th Annual Healthcare ConferenceLocation: The Lotte New York Palace, NY Presentation: Thursday, December 5, 8:00 a.m. EST Webcast:https:\/\/event.webcasts.com\/ A replay will be available for a limited time following the presentation on the Events &amp; Presentations portion of the\u00a0Humacyte\u00a0website. About\u00a0Humacyte Humacyte, Inc.\u00a0(Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable &hellip; Continue reading \"Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2024-12-02T14:17:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjQxMyM2NjE3OTYwIzIyMDk0MzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference","datePublished":"2024-12-02T14:17:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/"},"wordCount":374,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjQxMyM2NjE3OTYwIzIyMDk0MzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/","name":"Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjQxMyM2NjE3OTYwIzIyMDk0MzY=","datePublished":"2024-12-02T14:17:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjQxMyM2NjE3OTYwIzIyMDk0MzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxMjQxMyM2NjE3OTYwIzIyMDk0MzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-at-the-piper-sandler-36th-annual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/791577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=791577"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/791577\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=791577"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=791577"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=791577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}